TY - GEN
T1 - NeTFactor, a framework for identifying transcriptional regulators of gene expression-based biomarkers
AU - Ahsen, Mehmet Eren
AU - Chun, Yoojin
AU - Grishin, Alexander
AU - Grishina, Galina
AU - Stolovitzky, Gustavo
AU - Pandey, Gaurav
AU - Bunyavanich, Supinda
N1 - Funding Information:
This study was enabled in part by computational resources provided by Scientific Computing at the Icahn School of Medicine at Mount Sinai. We thank Dr. Madhan Masilamani for sharing his perspectives on the design of cell-line experiments, and Dr. Avner Schlessinger for his advice on the preparation of this manuscript. This work was supported by NIH grants R01AI118833 and K08AI093538 to SB, and R01GM114434 to GP, a pilot project grant from the Mount Sinai Mindich Child Health and Development Institute to SB and GP, and an IBM Faculty Award to GP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Publisher Copyright:
© 2020 Owner/Author.
PY - 2020/9/21
Y1 - 2020/9/21
N2 - Biological and regulatory mechanisms underlying many multi-gene expression-based disease biomarkers are often not readily evident. We describe an innovative framework, NeTFactor, that combines network analyses with gene expression data to identify transcription factors (TFs) that significantly and maximally regulate such a biomarker. NeTFactor uses a computationally-inferred context-specific gene regulatory network and applies topological, statistical, and optimization methods to identify regulator TFs. Application of NeTFactor to a multi-gene expression-based asthma biomarker identified ETS translocation variant 4 (ETV4) and peroxisome proliferator-Activated receptor gamma (PPARG) as the biomarker's most significant TF regulators. siRNA-based knock down of these TFs in an airway epithelial cell line model demonstrated significant reduction of cytokine expression relevant to asthma, validating NeTFactor's top-scoring findings. While PPARG has been associated with airway inflammation, ETV4 has not yet been implicated in asthma, thus indicating the possibility of novel, disease-relevant discovery by NeTFactor. We also show that NeTFactor's results are robust when the gene regulatory network and biomarker are derived from independent data. Additionally, our application of NeTFactor to a different disease biomarker identified TF regulators of interest. These results illustrate that the application of NeTFactor to multi-gene expression-based biomarkers could yield valuable insights into regulatory mechanisms and biological processes underlying disease.
AB - Biological and regulatory mechanisms underlying many multi-gene expression-based disease biomarkers are often not readily evident. We describe an innovative framework, NeTFactor, that combines network analyses with gene expression data to identify transcription factors (TFs) that significantly and maximally regulate such a biomarker. NeTFactor uses a computationally-inferred context-specific gene regulatory network and applies topological, statistical, and optimization methods to identify regulator TFs. Application of NeTFactor to a multi-gene expression-based asthma biomarker identified ETS translocation variant 4 (ETV4) and peroxisome proliferator-Activated receptor gamma (PPARG) as the biomarker's most significant TF regulators. siRNA-based knock down of these TFs in an airway epithelial cell line model demonstrated significant reduction of cytokine expression relevant to asthma, validating NeTFactor's top-scoring findings. While PPARG has been associated with airway inflammation, ETV4 has not yet been implicated in asthma, thus indicating the possibility of novel, disease-relevant discovery by NeTFactor. We also show that NeTFactor's results are robust when the gene regulatory network and biomarker are derived from independent data. Additionally, our application of NeTFactor to a different disease biomarker identified TF regulators of interest. These results illustrate that the application of NeTFactor to multi-gene expression-based biomarkers could yield valuable insights into regulatory mechanisms and biological processes underlying disease.
UR - http://www.scopus.com/inward/record.url?scp=85096990082&partnerID=8YFLogxK
U2 - 10.1145/3388440.3414207
DO - 10.1145/3388440.3414207
M3 - Conference contribution
AN - SCOPUS:85096990082
T3 - Proceedings of the 11th ACM International Conference on Bioinformatics, Computational Biology and Health Informatics, BCB 2020
BT - Proceedings of the 11th ACM International Conference on Bioinformatics, Computational Biology and Health Informatics, BCB 2020
PB - Association for Computing Machinery, Inc
T2 - 11th ACM International Conference on Bioinformatics, Computational Biology and Health Informatics, BCB 2020
Y2 - 21 September 2020 through 24 September 2020
ER -